Compare UUUU & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UUUU | ADMA |
|---|---|---|
| Founded | 1987 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2006 | 2012 |
| Metric | UUUU | ADMA |
|---|---|---|
| Price | $6.71 | $12.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $23.69 | $17.00 |
| AVG Volume (30 Days) | ★ 8.4M | 3.3M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | ★ $65,922,000.00 | $42,219,783.00 |
| Revenue This Year | $87.32 | $4.93 |
| Revenue Next Year | $107.55 | $17.59 |
| P/E Ratio | ★ N/A | $18.39 |
| Revenue Growth | N/A | ★ 43.85 |
| 52 Week Low | $6.86 | $7.21 |
| 52 Week High | $27.90 | $20.46 |
| Indicator | UUUU | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 24.36 | 69.84 |
| Support Level | N/A | $8.31 |
| Resistance Level | $8.53 | $16.77 |
| Average True Range (ATR) | 0.51 | 0.59 |
| MACD | 0.01 | 0.14 |
| Stochastic Oscillator | 21.36 | 80.26 |
Energy Fuels Inc is a critical mineral company based in the U.S. It produces several critical minerals, including uranium, vanadium, REEs (including NdPr, Dy and Tb) and HMS (including titanium and zirconium minerals). The company's project portfolio comprises uranium properties like Pinyon Plain Project, White Mesa Mill, Roca Honda Project, etc.; Heavy Minerals Sands project like Vara Mada Project, Donald Project, Bahia Project, etc.; the Nichols Ranch Project, and several other properties. The firm's reportable segments are: Uranium, REE, and HMS. Key revenue is generated from the Uranium segment, which is involved in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties, and the recycling of uranium-bearing materials generated by third parties.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.